Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Details)

v3.10.0.1
Revenue Recognition (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Total revenues   $ 1,807,042   $ 1,717,070 $ 5,076,744 $ 5,700,147
Service and Other Revenues [Member]            
Total revenues $ 67,238 67,238 $ 88,635 88,635 385,742 256,860
Rental, Service, Installation, Training, Shipping And Other [Member]            
Total revenues   62,238   88,635    
Biologics and drug delivery [Member]            
Total revenues   5,000   167,000
Product Revenue [Member]            
Total revenues   1,739,804   1,628,435 4,691,002 5,443,287
Functional Neurology [Member]            
Total revenues   1,448,850   1,284,029 3,787,712 4,229,192
Biologics And Drug Delivery [Member]            
Total revenues   190,993   136,833 483,251 291,023
Capital Equipment [Member]            
Total revenues   $ 99,961   $ 207,573 420,039 923,072
Capital Equipment and Other [Member]            
Total revenues         $ 218,742 $ 256,860